Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.

Oncotarget · 2014 · PMC4322974 · PMID 25473892

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Abt-737 treatment prolonged the survival of tumor-bearing animals to a highly significant degree, compared with DMSO-treated animals (Fig. 6A ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.